These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Use of Intravenous Sotalol in Cardiac Arrhythmias. Samanta R; Thiagalingam A; Turner C; Lakkireddy DJ; Kovoor P Heart Lung Circ; 2018 Nov; 27(11):1318-1326. PubMed ID: 29853342 [TBL] [Abstract][Full Text] [Related]
4. Feasibility and Safety of Intravenous Sotalol Loading in Adult Patients With Atrial Fibrillation (DASH-AF). Lakkireddy D; Ahmed A; Atkins D; Bawa D; Garg J; Bush J; Charate R; Bommana S; Pothineni NVK; Kabra R; Darden D; Koreber S; Tummala R; Vasamreddy C; Park P; Mohanty S; Gopinathannair R; Seo BW; Natale A; Kennedy R JACC Clin Electrophysiol; 2023 Apr; 9(4):555-564. PubMed ID: 37014289 [TBL] [Abstract][Full Text] [Related]
5. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias. Fitton A; Sorkin EM Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652 [TBL] [Abstract][Full Text] [Related]
6. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group. Vos MA; Golitsyn SR; Stangl K; Ruda MY; Van Wijk LV; Harry JD; Perry KT; Touboul P; Steinbeck G; Wellens HJ Heart; 1998 Jun; 79(6):568-75. PubMed ID: 10078083 [TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol. Advani SV; Singh BN Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009 [TBL] [Abstract][Full Text] [Related]
8. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638 [TBL] [Abstract][Full Text] [Related]
9. Sotalol: An important new antiarrhythmic. Anderson JL; Prystowsky EN Am Heart J; 1999 Mar; 137(3):388-409. PubMed ID: 10047618 [TBL] [Abstract][Full Text] [Related]
10. Intravenous Sotalol for the Treatment of Ventricular Dysrhythmias in an Infant on Extracorporeal Membrane Oxygenation. Jacobson JL; Somberg JC; Nguyen HH Pediatr Cardiol; 2020 Feb; 41(2):418-422. PubMed ID: 31664485 [TBL] [Abstract][Full Text] [Related]
11. Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay. Liu AY; Charron J; Fugaro D; Spoolstra S; Kaplan R; Lohrmann G; Gao X; Gay H; Passman R; Kim S; Lin AC; Chicos A; Arora R; Patil K; Pfenniger A; Knight BP; Verma N J Cardiovasc Electrophysiol; 2023 Mar; 34(3):502-506. PubMed ID: 36640424 [TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias. Nademanee K; Feld G; Hendrickson J; Singh PN; Singh BN Circulation; 1985 Sep; 72(3):555-64. PubMed ID: 4017207 [TBL] [Abstract][Full Text] [Related]
13. New antiarrhythmic drug in pediatric use: sotalol. Pfammatter JP; Paul T Pediatr Cardiol; 1997; 18(1):28-34. PubMed ID: 8960489 [TBL] [Abstract][Full Text] [Related]
14. [Therapy of atrial fibrillation with class III anti-arrhythmia agents]. Follath F; Candinas R; Frielingsdorf J Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249 [TBL] [Abstract][Full Text] [Related]
15. Effects of the new class III antiarrhythmic drug MS-551 and d-sotalol on canine coronary ligation-reperfusion ventricular arrhythmias. Hashimoto K; Haruno A; Hirasawa A; Awaji T; Xue Y; Wu Z Jpn J Pharmacol; 1995 May; 68(1):1-9. PubMed ID: 7494370 [TBL] [Abstract][Full Text] [Related]
16. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304 [TBL] [Abstract][Full Text] [Related]
17. Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation. Lenhoff H; Darpö B; Page A; Couderc JP; Tornvall P; Frick M Ann Noninvasive Electrocardiol; 2021 Jul; 26(4):e12834. PubMed ID: 33629473 [TBL] [Abstract][Full Text] [Related]
18. [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias]. Paul T; Lehmann C; Pfammatter JP; Kallfelz HC Z Kardiol; 1994 Dec; 83(12):891-7. PubMed ID: 7531374 [TBL] [Abstract][Full Text] [Related]
19. Safety and feasibility of intravenous sotalol loading for the prevention of ventricular arrhythmias. Sehgal A; Gangadharan A; Carneiro HA; Peigh G; Charron J; Lohrmann G; Elsayed M; Baman J; Pfenniger A; Patil K; Chicos A; Arora R; Kim SS; Lin A; Passman R; Knight BP; Verma N J Interv Card Electrophysiol; 2024 May; ():. PubMed ID: 38761294 [TBL] [Abstract][Full Text] [Related]
20. Comparison of a standard versus accelerated dosing regimen for D,L-sotalol for the treatment of atrial and ventricular dysrhythmias. Kim RJ; Juriansz GJ; Jones DR; Gerling BR; Holzberger PT; Greenberg ML Pacing Clin Electrophysiol; 2006 Nov; 29(11):1219-25. PubMed ID: 17100674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]